companydata.dkcompanydata.dk

Copenhagen Pharma Consulting ApS: Financial statements 2024

CVR: 41537388

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

Copenhagen Pharma Consulting ApS (CVR 41537388) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 2,617,035 and a net result of DKK 558,252 compared with DKK 335,687 the year before. That is a decrease of 10.7% compared with the year before. Equity in the 2024 report amounted to DKK 1,682,299. The solvency ratio was 70%. The company had 2 employees in the financial year.

Gross Profit
DKK 2,617,035
Profit/Loss
DKK 558,252
Equity
DKK 1,682,299
Total Assets
DKK 2,402,040
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-2.6M558K1.7M2
2023-2.9M336K1.2M2
2022-1.3M-38K906K2

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Copenhagen Pharma Consulting ApS: The 2023 annual report is outFeb 13, 2024

Copenhagen Pharma Consulting ApS has published its annual report for 2023. Gross profit came to DKK 2,931,273, and the net result was DKK 335,687.

About Copenhagen Pharma Consulting ApS

Copenhagen Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Vanløse, founded in 2020. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Lars Holten-Andersen. The company is owned by Obi1 Holding ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 3,364,006 and a net result of DKK 419,568 compared with DKK 558,252 the year before. Equity in the 2025 report amounted to DKK 601,867.

Source: annual report 2025, Danish Business Authority

Other financial years